(Q39392327)

11 September 2017

Bromocriptine and levodopa (with or without carbidopa) in parkinsonism (English)

2 references

11 September 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59850

10 April 2022

1 reference

(S)-(−)-carbidopa monohydrate

1 reference

inferred from title

parkinsonian syndrome

1 reference

7

D B Calne

1 reference

11 September 2017

R. Kartzinel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59850

10 April 2022

P. TEYCHENNE

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59850

10 April 2022

M. M. Gillespie

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59850

10 April 2022

M. Perlow

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59850

10 April 2022

A. C. Gielen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59850

10 April 2022

D. A. Sadowsky

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A59850

10 April 2022

language of work or name

English

0 references

publication date

1 August 1976

1 reference

11 September 2017

7 August 1976

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=59850

full work available at URL

10 April 2022

https://api.elsevier.com/content/article/PII:S0140673676907285?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(76)90728-5

https://api.elsevier.com/content/article/PII:S0140673676907285?httpAccept=text/plain

10 April 2022

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(76)90728-5

10 April 2022

1 reference

11 September 2017

2

1 reference

11 September 2017

7980

1 reference

11 September 2017

272-275

1 reference

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Long-lasting anti-tremor induced by 2-Br-alpha-ergocryptine in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Suppression of Puerperal Lactation with an Ergot Alkaloid: A Double-blind Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Bromocriptine in Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Treatment of parkinsonism with bromocriptine.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Idiopathic parkinsonism treated with bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Studies with bromocriptine. Part 2. Double-blind comparison with levodopa in idiopathic parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Treatment of Parkinson's disease with aporphines. Possible role of growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Parkinson's Disease: Activity of L-Dopa Decarboxylase in Discrete Brain Regions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Effect of CB 154 (2-bromo-alpha-ergocryptine) on paralysis agitans compared with Madopar in a double-blind, cross-over trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

Studies on the antiparkinsonian efficacy of lergotrile

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2990728-5

1 reference

7 January 2021

2

52

121

Fuxe

1974

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(76)90728-5

10 April 2022

Identifiers

1 reference

11 September 2017

1 reference